Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Pivotal Comparative Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of CG-0255 Besylate and Plavix® in Healthy Participants
CG-0255 is a novel investigational prodrug of the active metabolite of Plavix®， but with different active metabolite conversion routes. This is a randomized, o…
Acute Coronary Syndromes (ACS)Recent Myocardial InfarctionRecent Stroke+1 more
Estimated
~$10 – $8,750
Shanghai CureGene Pharmaceutical Co., Ltd.NCT07619885
Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants With Prior Myocardial Infarction Who Have Elevated Coronary Inflammation Based on FAI Score Assessed by CCTA
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarcti…
Acute Coronary SyndromesCoronary Arterial Disease (CAD)Inflammation+3 more
Estimated
~$10 – $7,500
AbcentraNCT06927739